References
- Bello BD, Spinillo A, Alberizzi P, et al (2009). Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples. J Clin Microbiol, 47, 2175-80. https://doi.org/10.1128/JCM.00286-09
- Bharti AC, Shukla S, Mahata S, et al (2010). Human papillomavirus and control of cervical cancer in India. Expert Rev Obstet Gynecol, 5, 329-46. https://doi.org/10.1586/eog.10.23
- Bhatla N, Lal N, Bao YP, et al (2008). A meta-analysis of human papillomavirus type-distribution in women form South Asia: Implication for vaccination. Vaccine, 26, 2811-7. https://doi.org/10.1016/j.vaccine.2008.03.047
- Ciapponi A, Bardach A, Glujovsky D, et al (2011). Type-specific hpv prevalence in cervical cancer and high-grade lesion in latin america and the caribbean: systematic review and meta-analysis. PLOS one,6, 1-15.
- Characterization of human papillomavirus type 16 from infected Thai women with different cytological finding. Virus Genes, 39, 30-8.
- Correnti M, Medina F, Cavazza ME, et al (2011). Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesion in Venezuelan women. Gynecologic Oncol,121, 517-31.
- Dowhanick JJ, McBride AA, Howley PM (1995). Suppression of cellular proliferation by the papillomavirus E2 protein, J Virol, 69, 7791-9.
- Gravitt PE, van Doorn LJ, Quint W, et al (2007). Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol, 45, 3245-50. https://doi.org/10.1128/JCM.00216-07
- Human Papillomavirus Typing Assay Using Formalin-Fixed Paraffin-Embedded Cervical Biopsy Samples. J Clin Microbiol, 47, 2175-80.
- International Agency for Research on Cancer (1995). IARC Monograph on the Evaluation of Carcinogenic Risks to Human, Vol 64. Human papillomavius. IARC, Lyon.
- Jacob MV, van den Brule AJ, Snijder PJ, et al (1996). A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol , 49, 223-9. https://doi.org/10.1002/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D
- Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Entire genome.
- Mateos Lindemann ML, Sanchez Calvo JM, Chacon de Antonio J, et al (2011). Prevalence and distribution of high-risk genotypes of hpv in women with severe cervical lesion in madrid, spain: importance of detecting genotype 16 and other high-risk genotypes. Adv Prev Med, 10,2011.
- Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19, 1-5. https://doi.org/10.1016/S1386-6532(00)00125-6
- Ramet J, van Esso D, Meszner Z (2011). Positive paper- HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians. Eur J Pediatr, 170, 309-21. https://doi.org/10.1007/s00431-010-1265-9
- Van Hamont D, van Ham MA, Bakkers JM, et al (2006). Evaluation of the SPF-10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol, 449, 3122-9.
- Villiers EM, Fanquet C, Broker TR, et al (2004). Classification of papilloma-virus. Virology, 324, 17-27. https://doi.org/10.1016/j.virol.2004.03.033
- Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- World Health Organization (2010). Human paillomavirus Laboratory Manual. 1st ed. HPV Laboratory Network, WHO: Switzerland.
- Zur Hausen H (2002). Papillomavirus and cancer: from basic studies to clinical application. Nature Rev, 2, 342-50. https://doi.org/10.1038/nrc798
Cited by
- Human Papillomavirus Genotypes Profile in Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5781
- Prevalence of High Risk Human Papillomavirus Infection with Different Cervical Cytological Features among Women Undergoing Health Examination at the National Cancer Institute, Thailand vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5879
- Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Cancer Risk in a Nested Case-Control Study in North-East Thailand vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1497
- HPV Detection and Genotyping in Vulvar Squamous Cell Carcinoma in Northern Thailand vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3773
- CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro vol.35, pp.3, 2016, https://doi.org/10.3892/or.2015.4521
- Molecular Genotyping of Human Papillomavirus L1 Gene in Low-Risk and High-Risk Populations in Bangkok vol.42, pp.4, 2015, https://doi.org/10.1097/OLQ.0000000000000259
- High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand vol.88, pp.1, 2015, https://doi.org/10.1002/jmv.24290